Information Journal Paper
APA:
Copy. (2017). Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 139(2), 703-705. SID. https://sid.ir/paper/782405/en
Vancouver:
Copy. Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY[Internet]. 2017;139(2):703-705. Available from: https://sid.ir/paper/782405/en
IEEE:
Copy, “Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect,” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 139, no. 2, pp. 703–705, 2017, [Online]. Available: https://sid.ir/paper/782405/en